Description
Composition (Each Tablet Contains):
-
Febuxostat – 40 mg
Form: Oral Tablet
Pack Size: 10×10 Alu-Alu
Product Description:
DEBUXOSTAT®‑40 contains Febuxostat, a non-purine selective xanthine oxidase inhibitor used for the long-term management of chronic hyperuricemia and gout. By reducing uric acid production in the body, it helps prevent painful gout attacks, joint inflammation, and urate crystal buildup.
It is especially beneficial for patients unresponsive or intolerant to allopurinol, offering better uric acid control and tolerability.
Key Benefits:
-
Effectively lowers serum uric acid levels
-
Prevents recurrent gout flare-ups and tophi formation
-
Safer alternative in patients with mild to moderate renal impairment
-
Suitable for long-term uric acid management
-
Improves joint function and quality of life in chronic gout sufferers
How It Works:
Febuxostat selectively inhibits xanthine oxidase, the key enzyme responsible for converting purines into uric acid. By blocking this pathway, DEBUXOSTAT®‑40 helps reduce uric acid production at the source, lowering the risk of crystal formation in joints and kidneys.
How to Use:
-
Take 1 tablet once daily, with or without food
-
Swallow whole with a glass of water
-
Consistency is key — use daily to maintain target uric acid levels
-
Always follow your physician’s instructions
Safety Advice:
-
Drink plenty of fluids throughout the day
-
Avoid alcohol and purine-rich foods (red meat, shellfish, etc.)
-
Do not start during an active gout attack; wait until the flare subsides
-
Regularly monitor serum uric acid and liver function tests
Precautions:
-
Not recommended during pregnancy or breastfeeding unless advised
-
Use with caution in patients with severe liver disease or cardiovascular risk
-
May cause mild joint pain or rash during initiation; consult your doctor if symptoms persist
-
Store in a cool, dry place below 25°C and protect from moisture
Reviews
There are no reviews yet.